NAPRT Silencing in FH-Deficient R…via NAD+ Depletion.

🔬 Peer-reviewed

NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion.

Noronha KJ, Lucas KN, Paradkar S, Edmonds J, Friedman S et al.

Molecular cancer research : MCR · 2024

Findings

PubMed study on Di-C12-15 Alkyl Fumarate in cosmetics/dermatology

Design

Review

Evidence

Moderate

Journal

Molecular cancer research : MCR

Ingredients studied